Adaptimmune Therapeutics PLC - SPONDS ADR (ADAP)

Q2 2016 13F Holders as of 6/30/2016

Type / Class
Equity / SPONDS ADR
Number of holders
46
Total Shares
31.9M
Shares change
-137K
Total reported value, excl. options
$260M
Value change
-$1.11M
Put/Call ratio
0
Number of buys
14
Number of sells
-20
Price
$8.15
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.